Terozin Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Warnings Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Terazosin HCl

Indications/Uses

Management of HTN. Relief of urinary obstruction symptoms in benign prostatic hyperplasia.

Click to view Terozin detailed prescribing information

Dosage/Direction for Use

HTN Initially 1 mg at bedtime. Maintenance dose: 2-10 mg once daily. Max: 20 mg daily in single or 2 divided doses.

Click to view Terozin detailed prescribing information

Administration

May be taken with or without food.

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Terozin detailed prescribing information

Special Precautions

Risk of sudden collapse following initial dose. Patients w/ renal or hepatic impairment; angina pectoris. May cause drowsiness or dizziness; do not drive or operate machinery. Elderly.

Click to view Terozin detailed prescribing information

Adverse Reactions

Dizziness, drowsiness, headache, lack of energy, nausea & palpitations.

Click to view Terozin detailed prescribing information

Drug Interactions

Enhanced hypotensive effects w/ diuretics, other antihypertensives, alcohol & other hypotension-causing drugs. Increased risk of 1st-dose hypotension w/ β-blockers or Ca channel blockers.

Click to view Terozin detailed prescribing information

Storage

View Terozin storage conditions for details to ensure optimal shelf-life.

Description

View Terozin description for details of the chemical structure and excipients (inactive components).

Action

View Terozin mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Drugs for Bladder & Prostate Disorders / Other Antihypertensives

ATC Classification

G04CA03 - terazosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.

Regulatory Classification

Presentation/Packing

Form

Terozin tab 2 mg

Packing/Price

30's (P1,110/box)

Form

Terozin tab 5 mg

Packing/Price

24's (P1,416/box)

Terozin

terazosin

Manufacturer:

Ultramed

Distributor:

Ultramed